$28.72
4.51%
NYSE, Tue, May 20 2025
ISIN
US62548M1009
Symbol
MPLN

Claritev Stock price

$28.72
+9.15 46.76% 1M
+22.27 345.27% 6M
+13.94 94.32% YTD
+6.88 31.48% 1Y
-161.28 84.88% 3Y
-375.28 92.89% 5Y
-360.08 92.61% 10Y
NYSE, Closing price Tue, May 20 2025
+1.24 4.51%
ISIN
US62548M1009
Symbol
MPLN
Sector

Key metrics

Market capitalization $472.05m
Enterprise Value $5.07b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.47
P/S ratio (TTM) P/S ratio 0.51
P/B ratio (TTM) P/B ratio 31.84
Revenue growth (TTM) Revenue growth -3.33%
Revenue (TTM) Revenue $927.45m
EBIT (operating result TTM) EBIT $78.77m
Free Cash Flow (TTM) Free Cash Flow $-103.48m
Cash position $33.90m
EPS (TTM) EPS $-72.94
P/S forward 0.51
EV/Sales forward 5.50
Short interest 4.72%
Show more

Is Claritev a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Claritev Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Claritev forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a Claritev forecast:

Buy
33%
Hold
67%

Financial data from Claritev

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
927 927
3% 3%
100%
- Direct Costs 675 675
2% 2%
73%
252 252
15% 15%
27%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
516 516
12% 12%
56%
- Depreciation and Amortization 438 438
2% 2%
47%
EBIT (Operating Income) EBIT 79 79
50% 50%
8%
Net Profit -1,177 -1,177
86% 86%
-127%

In millions USD.

Don't miss a Thing! We will send you all news about Claritev directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Claritev Stock News

Neutral
Business Wire
2 months ago
SAN DIEGO--(BUSINESS WIRE)-- #5hmC--ClearNote Health's Avantect Pancreatic Cancer Test will now be available to members accessing Claritev's national PHCS and MultiPlan Networks.
Neutral
Seeking Alpha
3 months ago
Claritev Corporation (MPLN) Q4 2024 Earnings Call Transcript
Neutral
Business Wire
3 months ago
NEW YORK--(BUSINESS WIRE)--Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025.
More Claritev News

Company Profile

MultiPlan Corp. provides healthcare cost management solutions. It uses technology-enabled provider network, negotiation, claim pricing and payment accuracy services as building blocks for medical and dental payors to customize the healthcare cost management programs. The company was founded in 1980 and is headquartered in New York, NY.

Head office United States
CEO Travis Dalton
Employees 2,700
Founded 1980
Website www.multiplan.us

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today